CP and neoplasm: In contrast, CP treatment of TKO;Smyd3-mutant mice triggered regression of disease with significantly reduced tumor volume (Fig. 7D and E), decrease in cell proliferation (Fig. 7G), and increase in cell apoptosis (Fig. 7H).